[1] NG K H, Brady Z, NG A H, et al. The status of radiation protection in medicine in the Asia-Pacific region [J]. J Med Imaging Radiat Oncol, 2021, 65(4): 464-470. [2] Dauer L T, Yorke E, Williamson M, et al. Radiotherapeutic implications of the updated ICRP thresholds for tissue reactions related to cataracts and circulatory diseases [J]. Ann ICRP, 2018, 47(3-4): 196-213. [3] HUANG R, ZHOU Y, HU S, et al. Radiotherapy exposure in cancer patients and subsequent risk of stroke: A systematic review and meta-analysis [J]. Front Neurol, 2019, 10: 1-12. [4] Ainsbury E A, Bouffler S D, Dörr W, et al. Radiation cataractogenesis: A review of recent studies [J]. Radiat Res, 2009, 172(1): 1-9. [5] Sumner D. Health effects resulting from the Chernobyl accident [J]. Med Confl Surviv, 2007, 23(1): 31-45. [6] Pastel R H. Radiophobia: long-term psychological consequences of Chernobyl [J]. Mil Med, 2002, 167(2 Suppl): 134-136. [7] Miller K D, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(5): 409-436. [8] Koutroumpakis E, Deswal A, Yusuf S W, et al. Radiation-induced cardiovascular disease: Mechanisms, prevention, and treatment [J]. Curr Oncol Rep, 2022, 24(5): 543-553. [9] Little M P, Azizova T V, Richardson D B, et al. Ionising radiation and cardiovascular disease: Systematic review and meta-analysis [J]. Bmj, 2023, 380: 1-16. [10] Darby S C, Ewertz M, Mcgale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer [J]. N Engl J Med, 2013, 368(11): 987-998. [11] Carlson L E, Watt G P, Tonorezos E S, et al. Coronary artery disease in young women after radiation therapy for breast cancer: The WECARE study [J]. JACC Cardio Oncol, 2021, 3(3): 381-392. [12] Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003 [J]. Bmj, 2010, 340: 1-8. [13] Hinksman C A, Haylock R G E, Gillies M. Cerebrovascular disease mortality after occupational radiation exposure among the UK national registry for radiation workers cohort [J]. Radiat Res, 2022, 197(5): 459-470. [14] Cha E S, Zablotska L B, Bang Y J, et al. Occupational radiation exposure and morbidity of circulatory disease among diagnostic medical radiation workers in South Korea [J]. Occup Environ Med, 2020, 77(11): 752-760. [15] Lachumy S J, Oon C E, Deivanai S, et al. Herbal remedies for combating irradiation: A green anti-irradiation approach [J]. Asian Pac J Cancer Prev, 2013, 14(10): 5553-5565. [16] Stenke L, Lindberg K, Lagergren Lindberg M, et al. Coordination of management of the acute radiation syndrome [J]. Radiat Prot Dosimetry, 2018, 182(1): 80-84. [17] pereira-Caro G, Polyviou T, Ludwig I A, et al. Bioavailability of orange juice (poly)phenols: the impact of short-term cessation of training by male endurance athletes [J]. Am J Clin Nutr, 2017, 106(3): 791-800. [18] Ávila-Gálvez M, Giménez-Bastida J A, González-Sarrías A, et al. New insights into the metabolism of the flavanones eriocitrin and hesperidin: A comparative human pharmacokinetic study [J]. Antioxidants (Basel), 2021, 10(3):1-18. [19] Cho J. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin [J]. Arch Pharm Res, 2006, 29(8): 699-706. [20] HAO Y, WEI Z, WANG Z, et al. Biotransformation of flavonoids improves antimicrobial and anti-breast cancer activities in vitro [J]. Foods, 2021, 10(10):1-16. [21] Olas B. A review of in vitro studies of the anti-platelet potential of citrus fruit flavonoids [J]. Food Chem Toxicol, 2021, 150: 1-11. [22] Pyrzynska K. Hesperidin: A review on extraction methods, stability and biological activities [J]. Nutrients, 2022, 14(12):1-11. [23] Pradeep K, Park S H, KO K C. Hesperidin a flavanoglycone protects against gamma-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats [J]. Eur J Pharmacol, 2008, 587(1-3): 273-280. [24] Kalpana K B, Devipriya N, Srinivasan M, et al. Investigation of the radioprotective efficacy of hesperidin against gamma-radiation induced cellular damage in cultured human peripheral blood lymphocytes [J]. Mutat Res, 2009, 676(1-2): 54-61. [25] Pearce M S, Salotti J A, Little M P, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: A retrospective cohort study [J]. Lancet, 2012, 380(9840): 499-505. [26] Choi Y Y, Kim A, Lee Y, et al. The miR-126-5p and miR-212-3p in the extracellular vesicles activate monocytes in the early stage of radiation-induced vascular inflammation implicated in atherosclerosis [J]. J Extracell Vesicles, 2023, 12(5): 1-27. [27] Stewart F A, Heeneman S, Tepoele J, et al. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage [J]. Am J Pathol, 2006, 168(2): 649-658. [28] Boerma M, Wang J, Wondergem J, et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease [J]. Cancer Res, 2005, 65(8): 3100-3107. [29] Stewart F A, Seemann I, Hoving S, et al. Understanding radiation-induced cardiovascular damage and strategies for intervention [J]. Clin Oncol (R Coll Radiol), 2013, 25(10): 617-624. [30] Darby S C, Cutter D J, Boerma M, et al. Radiation-related heart disease: Current knowledge and future prospects [J]. Int J Radiat Oncol Biol Phys, 2010, 76(3): 656-665. [31] Rousseau M, Gaugler M H, Rodallec A, et al. RhoA GTPase regulates radiation-induced alterations in endothelial cell adhesion and migration [J]. Biochem Biophys Res Commun, 2011, 414(4): 750-755. [32] Rothkamm K, Barnard S, Moquet J, et al. DNA damage foci: Meaning and significance [J]. Environ Mol Mutagen, 2015, 56(6): 491-504. [33] Bonner W M, Redon C E, Dickey J S, et al. GammaH2AX and cancer [J]. Nat Rev Cancer, 2008, 8(12): 957-967. [34] ZHANG J, LIANG R, WANG K, et al. Novel CaMKII-δ inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia/reperfusion injury and inhibit tumor growth [J]. Circulation, 2022, 145(15): 1154-1168. [35] Roohbakhsh A, Parhiz H, Soltani F, et al. Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—A mini-review [J]. Life Sci, 2014, 113(1-2): 1-6. [36] ZHANG X, ZHOU Y, CHEONG M S, et al. Citri Reticulatae Pericarpium extract and flavonoids reduce inflammation in RAW 264.7 macrophages by inactivation of MAPK and NF-κB pathways [J]. Food Frontiers, 2022, 3(4): 785-795. |